Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 258,042,256
  • Shares Outstanding, K 2,532,806
  • Annual Sales, $ 60,115 M
  • Annual Income, $ 365,000 K
  • EBIT $ 16,048 M
  • EBITDA $ 19,920 M
  • 60-Month Beta 0.40
  • Price/Sales 4.31
  • Price/Cash Flow 33.63
  • Price/Book 5.94

Options Overview Details

View History
  • Implied Volatility 23.93% ( -2.40%)
  • Historical Volatility 16.54%
  • IV Percentile 88%
  • IV Rank 58.02%
  • IV High 30.32% on 10/28/24
  • IV Low 15.09% on 05/17/24
  • Put/Call Vol Ratio 1.20
  • Today's Volume 29,212
  • Volume Avg (30-Day) 39,085
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 440,613
  • Open Int (30-Day) 392,561

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.89
  • Number of Estimates 6
  • High Estimate 1.93
  • Low Estimate 1.83
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +6,200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
98.60 +3.33%
on 10/31/24
114.60 -11.10%
on 10/02/24
-12.86 (-11.21%)
since 10/01/24
3-Month
98.60 +3.33%
on 10/31/24
120.30 -15.31%
on 09/06/24
-11.94 (-10.49%)
since 08/01/24
52-Week
98.60 +3.33%
on 10/31/24
134.63 -24.33%
on 06/25/24
-0.97 (-0.94%)
since 11/01/23

Most Recent Stories

More News
Is It Time to Buy October's Worst-Performing Dow Jones Stocks?

The Dow finished October down slightly. Should you buy any of these blue chips?

MSFT : 410.37 (+0.99%)
MRK : 101.88 (-0.43%)
NKE : 78.06 (+1.21%)
DOW : 48.97 (-0.83%)
3 Magnificent Stocks Under $100 to Buy in November

The price could be right for these stocks.

AZN : 71.42 (+0.38%)
SMMT : 18.99 (+2.15%)
MRK : 101.88 (-0.43%)
EXEL : 34.12 (+2.77%)
2 Dividend Stocks to Buy for a Lifetime of Passive Income

These are the kinds of stocks that can allow investors to sleep easy at night.

MRK : 101.88 (-0.43%)
SMMT : 18.99 (+2.15%)
MDT : 90.07 (+0.92%)
MRNA : 54.63 (+0.50%)
ISRG : 506.34 (+0.50%)
Is Merck Stock a Buy?

The next few years might get bumpy for the pharmaceutical giant, but the longer term looks better.

MRK : 101.88 (-0.43%)
Merck (MRK) Q3 2024 Earnings Call Transcript

MRK earnings call for the period ending September 30, 2024.

MRK : 101.88 (-0.43%)
Merck: Q3 Earnings Snapshot

Merck: Q3 Earnings Snapshot

MRK : 101.88 (-0.43%)
3 Dividend Stocks That Could Raise Their Payouts in November

These dividend stocks can be excellent options for buy-and-hold investors.

MRK : 101.88 (-0.43%)
HPQ : 36.28 (+2.14%)
ADP : 288.18 (-0.37%)
Stocks Plunge Before the Open as Microsoft and Meta Weigh on Sentiment, U.S. Inflation Data and Earnings in Focus

December S&P 500 E-Mini futures (ESZ24) are down -0.77%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -1.09% this morning as investors digested quarterly earnings reports from Microsoft and...

META : 567.16 (-0.07%)
GOOGL : 171.29 (+0.11%)
AAPL : 222.91 (-1.33%)
MO : 53.87 (-1.08%)
BNP.FP : 63.040 (+0.46%)
SMCI : 26.05 (-10.51%)
MRK : 101.88 (-0.43%)
NQZ24 : 20,153.25s (+0.66%)
GRMN : 198.18 (-0.09%)
GLE.FP : 27.275 (+3.37%)
MSFT : 410.37 (+0.99%)
MA : 508.08 (+1.70%)
Stocks Set to Open Higher as Investors Await Key U.S. Economic Data and Big Tech Earnings

December S&P 500 E-Mini futures (ESZ24) are up +0.37%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.48% this morning as investors looked ahead to earnings reports from some of the biggest...

ALK : 49.23 (+2.76%)
GOOGL : 171.29 (+0.11%)
AAPL : 222.91 (-1.33%)
CVX : 153.07 (+2.86%)
F : 10.22 (-0.68%)
MRK : 101.88 (-0.43%)
NQZ24 : 20,153.25s (+0.66%)
DASH : 155.66 (-0.66%)
PFE : 28.09 (-0.74%)
MSFT : 410.37 (+0.99%)
MHK : 134.28 (+0.01%)
SBUX : 98.87 (+1.20%)
Where Will Merck Be in 5 Years?

There's a lot to like here.

MRK : 101.88 (-0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda,...

See More

Key Turning Points

3rd Resistance Point 104.17
2nd Resistance Point 103.45
1st Resistance Point 102.66
Last Price 101.88
1st Support Level 101.15
2nd Support Level 100.43
3rd Support Level 99.64

See More

52-Week High 134.63
Fibonacci 61.8% 120.87
Fibonacci 50% 116.62
Fibonacci 38.2% 112.36
Last Price 101.88
52-Week Low 98.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar